Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524563 · ClinicalTrials.gov registry record
Clinical Outcomes and Global Epidemiology -Data Coordinating Center
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 400
- Enrollment target
NCT00524563 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 400 participants.
The verdict
NCT00524563 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The primary objective is to assess for independent predictors of in-hospital mortality (up to 28 days) in patients with Acinetobacter bloodstream infection. Secondary Objectives include the following: To determine the impact of inactive empiric antimicrobial therapy, defined as receipt of empiric antimicrobial therapy with no in vitro activity against the offending isolate for at least 24hrs, on the outcome (end points defined below) of patients with Acinetobacter bloodstream infection. To determine the impact of carbapenem resistance and pan-drug resistance (defined as resistance to all antimicrobials except colistin and/or tigecycline if these agents were tested) on the outcome of patients with Acinetobacter bloodstream infection. To assess the efficacy of varying definitive therapies on the outcome of patients with Acinetobacter bloodstream infection. To characterize the molecular epidemiology of Acinetobacter on a global level, as determined by pulsed-field gel electrophoresis (PFGE) and other techniques, and to assess whether patient outcomes are clonally related and to characterize the mechanisms of resistance in Acinetobacter on a global scale.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2007-07 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524563
The ClinicalTrials.gov registry entry for NCT00524563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00524563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524563 about?
NCT00524563 is a clinical study titled "Clinical Outcomes and Global Epidemiology -Data Coordinating Center". The primary objective is to assess for independent predictors of in-hospital mortality (up to 28 days) in patients with Acinetobacter bloodstream infection. Secondary Objectives include the following: To determine the impact of inactive empiric antimicrobial therapy, defined as receipt of empiric an...
What is the current status of trial NCT00524563?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2007-07. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT00524563?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.